Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

Department of Neurology, The Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK Correspondence to: Dr M Hadjivassiliou, Department of Neurology, The ...

2 Department of Biostatistics and Medical Informatics, Hôpital Saint-Louis, 75010, Paris, France Background: The spectrum of cognitive alterations associated with CADASIL, a model of pure vascular ...

Amyotrophic Lateral Sclerosis (ALS) is a diverse neurodegenerative disorder affecting motor neurons, with ALS6 specifically linked to FUS gene mutations. This case report underscores the intricate ...

Background: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and exclusion of other known causes of the neurological symptoms, but this criterion does not separate ...

Correspondence to Dr Satoshi Kuwabara, Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp ...

Stiff person syndrome (SPS) is a chronic, progressive neurological disorder characterized by painful muscle spasms and rigidity with high titres of circulating anti-GAD antibodies. Intravenous ...

1 Department of Clinical Neurology, The Royal Hallamshire Hospital, Sheffield, UK 2 Department of Gastroenterology, The Royal Hallamshire Hospital Correspondence to: Dr M Hadjivassiliou, Department of ...

Peripheral neuropathies are classified as primarily demyelinating or axonal. Microstructural alterations of the nodal region are the key to understand the pathophysiology of neuropathies with ...

OBJECTIVE To identify the factors that determine quality of life (QoL) in patients with idiopathic Parkinson's disease in a population based sample. Quality of life (QoL) is increasingly recognised as ...

Dr Koskiniemi, Haartman Institute, Department of Virology, University of Helsinki, Haartmaninkatu 3, SF-00290, Helsinki, Finland. OBJECTIVE To compare the efficacy, tolerability, and safety of three ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...